Trinity Biotech secures regulatory approval for outsourced manufacturing

Trinity Biotech (TRIB) has received World Health Organization approval for the offshored and outsourced upstream manufacturing activities of its market leading Uni-Gold HIV rapid test, a well-established and cornerstone diagnostic product used in HIV screening programs internationally. This regulatory approval marks a further critical milestone in the Company’s comprehensive transformation plan aimed at driving sustainable profitability. This major regulatory approval enables Trinity Biotech to transition upstream production of Uni-Gold from its legacy in-house operations to a more cost-effective outsourced model, while maintaining the highest levels of product integrity and regulatory compliance.